2002
DOI: 10.1093/jnci/94.3.182
|View full text |Cite
|
Sign up to set email alerts
|

Lung Cancer Following Chemotherapy and Radiotherapy for Hodgkin's Disease

Abstract: Past treatments with alkylating agents and radiation therapy for Hodgkin's disease were associated with an increased risk of lung cancer in a dose-dependent and additive fashion. The precise risk estimates, however, should be interpreted cautiously, given the possible residual and enhancing effects of tobacco.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

14
328
1
9

Year Published

2003
2003
2023
2023

Publication Types

Select...
7
2

Relationship

0
9

Authors

Journals

citations
Cited by 510 publications
(360 citation statements)
references
References 38 publications
14
328
1
9
Order By: Relevance
“…The triple lung cancers in the present patient developed over the course of a year, during treatment for malignant lymphoma after initial diagnosis. The period of one year was quite short, but it was compatible with the second report, above (5). To the best of our knowledge, however, double second lung cancers after malignant lymphoma had not been reported before, nor have synchronous triple lung cancers.…”
Section: Case Reportsupporting
confidence: 87%
“…The triple lung cancers in the present patient developed over the course of a year, during treatment for malignant lymphoma after initial diagnosis. The period of one year was quite short, but it was compatible with the second report, above (5). To the best of our knowledge, however, double second lung cancers after malignant lymphoma had not been reported before, nor have synchronous triple lung cancers.…”
Section: Case Reportsupporting
confidence: 87%
“…In general, protracted exposures to the same total dose of X-radiation are associated with lower risks than those of an acute exposure, both for cancer and other endpoints [12]. Latency of cancer induction due to ionizing radiation exposure is well recognized, and available evidence indicates that the time from exposure to incidence of cancer for solid tumors is at least 5 years and more commonly 10-20 years [13].…”
Section: Biologic Effects Of Exposure To Ionizing Radiationmentioning
confidence: 99%
“…Newer studies of late effects characterized the risk further. [23][24][25][26][27][28] We now know that thoracic radiation in women treated under the age of 30 years results in a very high rate of breast cancer that approximates 30% at 30 years following treatment 25 but that this risk is much lower in women who received alkylating agent chemotherapy with no hormone replacement therapy. 27 We also know that heavy smokers after thoracic radiation for Hodgkin lymphoma have a 20 times higher risk of lung cancers while light or nonsmokers have a 7 times higher risk.…”
Section: Issues Of Late Effectsmentioning
confidence: 99%
“…27 We also know that heavy smokers after thoracic radiation for Hodgkin lymphoma have a 20 times higher risk of lung cancers while light or nonsmokers have a 7 times higher risk. 28 The dose and volume of radiation increase these risks, and newer treatment protocols that use lower radiation doses and reduced volumes should reduce the risk of second cancers. 29 Late effects of MOPP chemotherapy have been well characterized.…”
Section: Issues Of Late Effectsmentioning
confidence: 99%